Big news for APC Pharmacy-Facility Members: You now have access to a great new compounding-specific patient-reported outcomes tool: OutcomeMD.
There’s plenty of anecdotal evidence for positive patient outcomes, but not enough of the validated, standardized data FDA wants to see. The OutcomeMD platform will help change that, allowing APC to aggregate patient-reported outcome data while providing compounding pharmacy owners granular data on how their formulations are working for patients.
“The OutcomeMD platform is something long-needed in compounding: A means of collecting and aggregating patient outcomes data in a way that’s not just useful to the pharmacy but useful to the profession,” said APC’s CEO Scott Brunner, CAE.
Via a smartphone app, patients respond to questions about how their specific therapies are working. Owners in turn get data about those formulations using the same validated measures used in clinical trials (and that FDA uses in its database). And, with the owners’ permission, APC gets access to the aggregated metadata — scrubbed of HIPAA-protected details, of course — to share with FDA and demonstrate how patients benefit from compounded therapies.
Using OutcomeMD also provides direct benefits to you and your patients.
Thanks to our partnership with OutcomeMD, APC Pharmacy/Facility Members members receive more than half off OutcomeMD’s standard subscription rates.
Learn more about everything an OutcomeMD subscription provides at OutcomeMD.com.
Then reach out to Lorraine Kaiser at lkaiser@outcomemd.com to schedule your demo. You can even click here to schedule it directly.
Any questions? APC’s Jason Dunn — jason@a4pc.org or (918) 770-6333 — can help.